Hepatoprotective Effect of Kinar Leaf Juice on SGOT and SGPT Levels in a Preclinical Malaria Model
Abstract
Malaria infection caused by Plasmodium parasites can trigger organ disorders, especially the liver, which is characterized by increased levels of Serum Glutamic Oxaloacetic Transaminase (SGOT) and Serum Glutamic Pyruvic Transaminase (SGPT) enzymes due to oxidative stress and inflammatory responses. Kinar leaves (Kleinhovia hospita L.) are empirically rich in antioxidant bioactive content that has the potential as a hepatoprotective agent. This laboratory experimental study was conducted to test the potential of the kinar leaf juice to reduce SGOT and SGPT levels in mice (Mus musculus) infected with Plasmodium berghei. The test was carried out by dividing 15 mice into five treatment groups, including a positive control group infected, a control group given quinine 0.037 mg/head/day, and three treatment groups of kinar leaf juice with doses of 0.09 ml, 0.18 ml, and 0.36 ml/head/day for 4 days. Measurement of SGOT and SGPT levels was carried out using the spectrophotometric method, then the data were analyzed using ANOVA and Duncan's advanced test at a significance level of 5%. The results showed that P. berghei infection significantly increased SGOT levels from 50.0 U/L to 168.0 U/L and SGPT from 27.5 U/L to 75.3 U/L. Administration of kinar leaf juice at doses of 0.09 ml, 0.18 ml, and 0.36 ml was proven to be able to reduce SGOT levels to 29.3 U/L; 26.6 U/L; and 26.6 U/L, respectively, and SGPT levels to 25.0 U/L; 22.6 U/L; and 29.3 U/L (P < 0.05). This liver enzyme-lowering effect was comparable to, and even better than, the quinine treatment group (SGOT: 30.6 U/L; SGPT: 36.3 U/L). These findings demonstrate that quinar leaf juice has effective hepatoprotective activity in suppressing liver cell damage and restoring hepatic function in preclinical malaria models.
Downloads
Copyright (c) 2026 Reja Ropina Nusaaly, Adrien Jems Akiles Unitly, Efraim Samson, Amos Killay, La Eddy

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
1. Author retain copyright and grant the journal right of first publication with the work simultaneously licensed under a creative commons attribution license that allow others to share the work within an acknowledgement of the work’s authorship and initial publication of this journal.
2. Authors are able to enter into separate, additional contractual arrangementfor the non-exclusive distribution of the journal’s published version of the work (e.g. acknowledgement of its initial publication in this journal).
3. Authors are permitted and encouraged to post their work online(e.g. in institutional repositories or on their websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published works.




